Industry Partnering With Academia, Lessons Learned From The Cleveland Clinic
Source: Life Science Leader
In this executive virtual roundtable (EVR) segment, Rahul Aras, Ph.D., CEO of Iterion Therapeutics, a clinical stage company developing cancer therapeutics, discusses the decision to take a position at the Cleveland Clinic, and the important lessons learned regarding industry partnering with academic-type institutions. Adding to the conversation as it migrates to communicating the value proposition of their company (i.e., pitching) to investors are Steffen Mueller, Ph.D., cofounder and CSO, Codagenix, and Prem Premsrirut, M.D., Ph.D., CEO of Mirimus.
This website uses cookies to ensure you get the best experience on our website. Learn more